A novel senolytic drug, seno-7284 ameliorates aging phenotype and age-related cardiometabolic diseases
29 August 2020 (00:00 - 00:00)
Organised by:
About the speaker

Juntendo University School of Medicine, Tokyo (Japan)
51 More presentations in this session
Doctor J. Jehle (Bonn, DE)
Doctor E. Straessler (Berlin, DE)
Blocking of interleukin-1 suppresses both angiotensin II-induced renal inflammation and hypertension
Doctor T. Niida (Tokyo, JP)
Access the full session
The Event
ESC Congress 2020
29 August - 1 September 2020
